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Abstract
Background: Neuropathic pain (NP) is partially mediated by neuroinflammatory mechanisms, and
also modulates local neurogenic inflammation. Dietary lipids, in particular the total amount and
relative proportions of polyunsaturated fatty acids (PUFAs) of the ω-3 and ω-6 families, have been
reported to modify the threshold for thermal and mechanical allodynia in the partial sciatic nerve
ligation model of NP in rats. The effects of dietary lipids on other popular NP models, such as the
chronic constriction injury (CCI), have not yet been examined. It is also unknown whether dietary
PUFAs exert any effect on the capsaicin (CAP)-induced neurogenic inflammation under control or
NP conditions. In this study we investigated these interrelated phenomena in the trigeminal
territory, which has been much less explored, and for which not all data derived from limb nerves
can be directly applied.
Results: We studied the effects of a CCI of the infraorbital nerve (IoN) on the development of
mechanical allodynia and CAP-induced plasma extravasation in rats fed either a regular diet (RD),
or a modified diet (MD) with much lower total content and ω-3:ω-6 ratio of PUFAs. In rats kept
on MD, mechanical allodynia following CCI-IoN was more pronounced and developed earlier.
Extravasation was substantially increased in naive rats fed MD, and displayed differential diet-
depending changes one and four weeks after CCI-IoN. When compared with basal levels (in naive
and/or sham cases), the net effect of CCI-IoN on ipsilateral extravasation was a reduction in the
MD group, but an increase in the RD group, effectively neutralizing the original intergroup
differences.
Conclusion: In summary, PUFA intake reduces CAP-induced neurogenic plasma extravasation in
the trigeminal territory, and their removal significantly alters the mechanical allodynia and the
plasma extravasation that result from a unilateral CCI-IoN. It is likely that this "protective" effect
of dietary lipids is temporary. Also, the presence of contralateral effects of CCI-IoN precludes using
the contralateral side as control.
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Background
Chronic pain syndromes occur frequently in the trigemi-
nal territory. Even disregarding headaches and dental
pain, prevalence of orofacial pain reached 25–30% in a
population-based study in the UK [1]. The mechanisms of
neuropathic pain (NP) are multiple and still not fully
understood [2,3], and this knowledge is particularly defi-
cient when it comes to chronic pain in orofacial regions.
To date, a variety of neuropathic models in rodent's spinal
nerves have been developed, mostly based on limited or
partial injury inflicted at different nerve levels [4]. In the
trigeminal system, on the other hand, only the chronic
constriction injury of the infraorbital nerve (CCI-IoN) has
gained wide acceptance as a rodent model for the study of
trigeminal neuralgia [5,6]. Nociceptive behavior follow-
ing CCI-IoN is characterized by mechanical allodynia and
thermal hyperalgesia preceded by a transient phase of
lower responsiveness to mechanical and thermal stimuli
[5]. Except for a shorter onset latency of the positive symp-
toms, the CCI of the sciatic nerve leads to a similar out-
come [7]. In addition, sciatic CCI results in a marked
decrease of nerve stimulation-, substance P- or capsaicin
(CAP)-induced local plasma extravasation in its cutane-
ous territory [8-11]. Whether this hallmark of neurogenic
inflammation is likewise altered after CCI-IoN is still
unknown.
The response to noxious stimulation is known to be influ-
enced by diet, but this has been mostly proven for acute
responses [12-15]. A series of more recent studies, how-
ever, showed that consumption of a soy-rich diet prevents
the development of tactile allodynia and thermal hyperal-
gesia after a partial sciatic nerve ligation injury [16,17].
More specifically, dietary corn or soy fats suppressed tac-
tile allodynia and heat hyperalgesia, whereas soy and
casein proteins decreased heat hyperalgesia but had no
effect on tactile allodynia [18]. Dietary lipids and, in par-
ticular, the polyunsaturated fatty acids (PUFAs) in the diet
are known to affect many physiological processes, such as
inflammation, hemostasis, vascular tone, and immune
reactions, as well as a number of pathological conditions
in which chronic inflammation and/or immune reactions
are involved [19,20]. Not surprisingly, the value of food
rich in PUFAs or of PUFAs supplements to relieve the pain
that accompanies those conditions has been under sus-
tained scientific scrutiny along the last decades [21,22].
No data are available concerning the neurogenic inflam-
mation and the effects of dietary lipids for the trigeminal
territory. And it must be noted that the results derived
from experimental studies on the spinal systems cannot
be uncritically extrapolated to the trigeminal system,
because not all properties of the spinal ganglia and cord
are directly applicable to the trigeminal ganglion and
brain stem nuclei [23-27]. Hence the importance of char-
acterizing the specific features of NP in a trigeminal model
in order to better understand the mechanisms of orofacial
pain syndromes. Within this context, the purpose of this
study was to investigate, first, the effects of the CCI-IoN on
neurogenic inflammation, as measured by the degree of
Evans Blue (EB) extravasation after topical application of
capsaicin on the vibrissal pad, and second, to examine the
influence of altering the PUFA contents in the diet on the
mechanical allodynia and neurogenic inflammation that
result from CCI-IoN.
Results
Weight gain and general behavior
No obvious change could be detected in spontaneous
behavior in animals fed different diets, and after CCI or
sham surgery. Food intake was also apparently unaffected
by diet or surgery, and this was attested by the absence of
significant differences in weight gain from six weeks of age
to the day of perfusion between the rats fed regular rat
chow (RD) (from 218.3 ± 52.0 g to 362.4 ± 27.1 g) and
those fed modified diet (MD) (from 198.5 ± 21.9 g to
363.4 ± 19.0 g). Likewise, there were no weight differences
at perfusion between the unoperated, naive group (363.4
± 19.0 g), and the sham (356.4 ± 30.4 g) and CCI groups
(340.2 ± 13.5 g).
Behavioral tests
The baseline response threshold to mechanical stimuli
was similar in both diet groups (2.25 ± 0.32 g in RD vs.
1.94 ± 0.35 g in MD, expressed as bending force needed to
elicit 50% of positive responses), and exhibited a highly
significant decrease after CCI on the ipsilateral (Kruskal-
Wallis, p < 0.001) but not the contralateral side in both.
However, this decline in threshold appeared earlier and
was more pronounced in the MD group, which differed
very significantly from the RD group at 8 days postsurgery
(0.43 ± 0.16 g vs. 1.96 ± 0.45 g; p = 0.005). At 15 days the
difference showed statistical tendency (0.22 ± 0.11 g vs.
0.61 ± 0.26 g; p = 0.059), and by 26 days after surgery a
small difference was still observed (0.10 ± 0.04 g vs. 0.32
± 0.15 g), which did not reach significance. Side compar-
isons for each force tested also revealed a different time
course of mechanical allodynia for RD and MD groups,
showing an earlier onset of higher responsiveness in rats
fed MD (at day 8 postsurgery), but the same pattern of
side differences in MD and RD 26 days after surgery (Fig.
1). In the right side, contralateral to the CCI, the response
threshold after surgery was somewhat lower in rats fed
MD compared to those fed RD, although this difference
did not reach statistical significance.
Effects of diet on plasma extravasation in naive animals
CAP-induced plasma extravasation in unoperated animals
kept on MD (n = 14) was almost twice as large as that in
the RD group (n = 14; Fig. 2). Pooling both sides for eachMolecular Pain 2009, 5:8 http://www.molecularpain.com/content/5/1/8
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group, extravasation values were 12.38 ± 5.13 for RD, and
21.57 ± 9.46 for MD. This 72% difference was very signif-
icant even when each side was compared separately (p =
0.012 for the left sides, p < 0.001 for the right). Similar
values were obtained when comparisons between diet
groups were made for the sham-operated animals (9.8 ±
4.4 for RD, n = 9; 24.9 ± 11.7 for MD, n = 9; p = 0.002).
The effects of topical application of vehicle (VEH) or
saline (SAL) instead of CAP on naive rats was examined
only in the group fed MD, on the assumption that, in the
improbable case that those treatments altered basal
extravasation, such effect would be more marked under
no "pain-protecting" feeding conditions. Our results
(plotted in Fig. 3 for the left side) showed no differences
in extravasation (p > 0.60 in all cases) following applica-
tion of VEH (6.27 ± 1.72) or SAL (6.89 ± 3.09) on either
side, while both values differed significantly (p < 0.002)
from the extravasation elicited by CAP.
Effects of CCI-IoN on plasma extravasation
Side differences per diet group
The average left-right ratio of extravasation for each diet
group showed a progressive decrease of extravasation in
the constricted side, from a negligible ± 4% in naive
groups, to -7% (RD) or -9% (MD) at 8 days after surgery,
and -29% (RD) or -28% (MD) at 26 days. However,
because of a large interindividual variability, and because
of a similar (albeit less pronounced) decreasing trend in
the contralateral side, this reduction only reached statisti-
cal tendency (p = 0.054) 26 days after surgery in the RD
group (Fig. 4).
Differences between groups in the CCI (left) side
In the RD group, CAP-induced plasma extravasation
increased significantly after surgery with respect to both
naive (Kruskal-Wallis, p = 0.043) and sham-operated
groups (ANOVA, p < 0.001). Compared to the naive ani-
Diet modifies differently mechanical response thresholds Figure 1
Diet modifies differently mechanical response 
thresholds. Nociceptive responses to Von Frey hairs 
applied to the vibrissal pads in rats fed RD or MD at pre-sur-
gery time point and at three time intervals after a CCI-IoN 
performed on the left side. Data represent the mean ± SEM 
of n = 15 (Pre-surgery and 8 dps) and n = 9 (15 and 26 dps) 
animals. The unilateral constriction evoked in both diet 
groups a highly significant decrease in response threshold 
that evolved with time in the ipsilateral (p < 0.001) but not 
the contralateral side. Differences between diet groups were 
highly significant ipsilaterally to the surgery at 8 dps (* p = 
0.005), and showed statistical tendency at 15 dps (p = 0.059). 
Side differences were significant (arrows) at all postsurgery 
testing times (8 dps, p = 0.008; 15 dps, p = 0.01; 26 dps, p = 
0.005) in the MD group, but only at 15 dps (p = 0.04) and 26 
dps (p = 0.001) in the RD group.
CAP-induced plasma extravasation is larger in naive rats fed  MD Figure 2
CAP-induced plasma extravasation is larger in naive 
rats fed MD. Extravasation nearly doubled on both sides of 
the snout in animals maintained on MD (n = 14) compared to 
those on RD (n = 14; ** p < 0.01). Data represent means ± 
SD of normalized EB absorbance values (see Methods).Molecular Pain 2009, 5:8 http://www.molecularpain.com/content/5/1/8
Page 4 of 10
(page number not for citation purposes)
mals (Fig. 5), this increase reached a significant 68% at 8
days after surgery (* p = 0.017), but displayed a more
moderate 35% at 26 dps (showing statistical tendency, p
= 0.052). In contrast, in animals fed MD the extravasation
decreased with respect to naive animals. This decrease was
a non-significant 26% at 8 dps, but reached 34% at 26 dps
(p = 0.056). Compared to the sham-operated rats, the
extravasation increases observed in the RD group became
highly significant at 8 (p < 0.002) and 26 dps (p < 0.001),
whereas the moderate decreases detected in the MD group
remained below the significance level.
These findings indicate that the CCI elicited changes on
CAP-induced extravasation in opposite directions, which
depended on the different basal levels that were character-
istic of each diet. Moreover, no significant differences
were found on the side of the CCI between RD and MD
groups at any postsurgical time, suggesting that, at least by
8 days after CCI, the nerve injury has already imposed a
certain degree of CAP-induced extravasation, regardless
the initial, diet-dependent conditions.
Extravasation dependence on topical CAP in naive MD  groups Figure 3
Extravasation dependence on topical CAP in naive 
MD groups. Extravasation measured after application of 
either VEH (n = 6) or SAL (n = 5) did not reach one-third of 
the values reached after CAP (n = 14). Only results for the 
left side are shown (those on the right were essentially the 
same). Data represent means ± SD. ** p < 0.002.
CAP-induced extravasation tends to decrease with time in  the constricted side in both diet groups Figure 4
CAP-induced extravasation tends to decrease with 
time in the constricted side in both diet groups. Side 
comparisons within group showed a progressive relative 
decrease of extravasation in the constricted side. However, 
this reduction only reached statistical tendency (p = 0.054) 
26 days after surgery in the RD group. Data represent means 
± SD.
Extravasation differences between groups on the constricted  side Figure 5
Extravasation differences between groups on the 
constricted side. When compared with results in naive ani-
mals fed the same diet, the changes in CAP-induced extrava-
sation generated by the CCI had opposite directions, 
depending on the diet. In animals fed RD, the values of 
plasma extravasation increased significantly (p = 0.043) after 
surgery. This increase was most marked at 8 dps (* p = 
0.017), and more moderate at 26 dps (showing statistical ten-
dency, p = 0.052). In contrast, in animals fed MD the extrava-
sation decreased with respect to naive animals, and this 
decrease showed statistical tendency at 26 dps (p = 0.056). 
No significant differences were found in lesioned rats on the 
side of the CCI between RD and MD groups at any of the 
postsurgical times tested. Data represent means ± SD; 
number of cases as in Fig. 4.Molecular Pain 2009, 5:8 http://www.molecularpain.com/content/5/1/8
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Differences between groups in the contralateral (right) side
Following a unilateral CCI-IoN, the notable diet-depend-
ent difference in CAP-induced extravasation found in
naive rats also disappeared in the opposite side of the con-
striction. This was due to a large increase in extravasation
on the right vibrissal pad in animals fed RD at 8 (+75%, p
< 0.006) and 26 dps (+85%, p < 0.001), while only minor
(-23% and -12%, respectively) and non-significant reduc-
tions from the basal high levels of extravasation found in
naive rats were observed in the right side of animals fed
MD (Fig. 6). This resulted in no significant differences
between RD and MD groups at any of the postsurgical
times tested. Similar results were obtained when compar-
isons were made with the sham-operated animals, except
for somewhat larger differences with the operated groups,
which reached high significance in the RD group, and sta-
tistical tendency (0.05 < p < 0.08) in the MD group.
Discussion
In this study we aimed at investigating the effects of the
CCI-IoN on mechanical allodynia and neurogenic inflam-
mation in rats fed a standard diet, or a modified diet with
a very low content of PUFAs. The main findings of this
study are: 1, the mechanical allodynia in the trigeminal
territory following CCI-IoN is more pronounced, and
develops 1–2 weeks earlier when rats were deprived of
PUFAs in the diet; 2, CAP-induced plasma extravasation
in naive rats fed MD is nearly twice as large as in those fed
RD; 3, eight days after CCI-IoN the extravasation in the
operated side reaches similar levels in both diet groups; 4,
the CCI also causes a contralateral rise of extravasation,
but only in the RD group, bringing its levels to the same
range of those in the MD group; and 5, consequently, the
net effect of CCI-IoN on extravasation is a moderate
reduction in the MD group, but a significant increase in
the RD group, compared with basal levels (from naive
and/or sham cases).
CCI-IoN and neurogenic inflammation
Nerve injury underlying different neuropathic conditions
is known to reduce the flare response to topical applica-
tion of substance P, histamine or capsaicin [28,29]. A
related effect, consisting of reduction of vasodilatation
and decreased plasma extravasation, has been reported in
widely used models of neuropathy in the sciatic territory
in rats, such as the CCI of the sciatic nerve [9,11] or the
spinal nerve ligation [30]. The axon reflex-dependent
vasodilatation is normally mediated by antidromic activa-
tion of a subpopulation of Aδ and C fibers [8,10], but Aβ
fibers activated from injured or irritated target tissues may
also play a role, by centrally sensitizing C nociceptors
[31]. Plasma extravasation, however, depends not on Aδ
fibers [8], but on C fibers, because it is elicited by specific
antidromic stimulation of polymodal C fibers [32,33],
and is prevented by specifically blocking axoplasmic
transport in C fibers with colchicine [34].
We have shown that topical application of CAP to the
vibrissal pad also elicits neurogenic extravasation, which
is reduced ipsilaterally to a CCI-IoN. However, under
standard dietetic conditions, the actual levels of plasma
extravasation are increased bilaterally after performing a
unilateral constriction. This results in a net extravasation
increase in the constricted side, when compared with the
same side in naive or sham groups. To our knowledge,
similar intergroup comparisons are mostly lacking con-
cerning extravasation after chronic constriction or partial
nerve injury, not only in trigeminal fields, but also in the
more commonly studied sciatic or saphenous territories.
However, Yonehara and Yoshimura [11] showed a signif-
icant net reduction in EB released by CAP application or
nerve stimulation into the perfusate collected through a
subcutaneous cannula, 7 days after sciatic CCI. This differ-
ence with our results may be due not only to a local dam-
age created by the inserted cannula in that study, but also
to a different degree of nerve damage between the sciatic
and the trigeminal CCI models. Yonehara and Yoshimura
[11] used Bennett and Xie's [7] four-ligature model of sci-
atic CCI, which is reported to determine a nearly complete
loss of myelinated fibers and a substantial loss of unmy-
Extravasation differences between groups on the side con- tralateral to the constriction Figure 6
Extravasation differences between groups on the side 
contralateral to the constriction. The CAP-induced 
extravasation on the right vibrissal pad in animals fed RD 
increased very significantly (** p < 0.006) at 8 and 26 dps fol-
lowing a CCI of the left IoN. In contrast, no differences 
between naive and CCI-IoN groups were noticed in animals 
fed MD, which in all cases displayed high levels of extravasa-
tion on the right side. No significant differences were found 
on the contralateral side of the CCI between RD and MD 
groups at any of the postsurgical times tested. Data repre-
sent means ± SD; number of cases as in Fig. 4.Molecular Pain 2009, 5:8 http://www.molecularpain.com/content/5/1/8
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elinated axons, two weeks after ligation [35]. A similar
quantitative analysis is not yet available for the CCI-IoN
model, which used two loose ligatures [5], nor for our var-
iant, which used a single ligature. Qualitative observa-
tions by Anderson et al. [36] after a single ligature,
however, suggested a relatively moderate fiber loss three
weeks after CCI-IoN. In contrast, we have found that four
relatively tight ligatures applied to the IoN resulted in a
substantial fiber loss and a marked net reduction of EB
extravasation, but also -as previously reported by others
[37] – a less pronounced and less consistent mechanical
allodynia (unpublished findings).
Contralateral effects of nerve injury on extravasation
The appearance of contralateral effects after a unilateral
nerve injury has been known for a number of years. They
consist of a diversity of phenomena, from altered gene
expression to a range of functional and anatomical
changes in homotopical contralateral peripheral nerves,
sensory ganglia or motoneurons [38]. Acute contralateral
neurogenic responses, such as tissue edema or plasma
extravasation into the synovial space, have been described
following the induction of unilateral inflammation [39-
41]. More recently, Kelly et al. [42] showed that five days
after unilateral induction of inflammation in the rat knee
joint, EB extravasation in the contralateral knee joint was
increased, and this increase was accompanied by an ele-
vated rate of spontaneous activity in CAP-sensitive fibers
of the saphenous nerve (just above the incorporation of
the medial articular nerve). These observations are con-
sistent with our finding of an increased EB extravasation
in the vibrissal pad contralateral to the CCI-IoN. Although
a conclusive explanation for the contralateral effects is yet
to be obtained, it has been shown that a pharmacological
blockade of C and Aδ nociceptive fibers and/or sympa-
thetic fibers in the sciatic nerve blocks the sustained
peripheral vasodilatation elicited by a contralateral sciatic
CCI [43], supporting the early claim that both neural
components participate in what was called reflex neuro-
genic inflammation [39]. The role of the sympathetic sys-
tem for explaining the increase in peripheral extravasation
after partial limb nerve lesion is debated [30,44], but it
has been shown that SNL induces sympathetic fibers
sprouting not only in the ipsilateral but also the contralat-
eral DRG [45-47]. Less likely, however, would be a similar
role for the sympathetic innervation in the trigeminal ter-
ritory after unilateral CCI-IoN, given the absence of sym-
pathetic fiber sprouting in the trigeminal ganglion after
nerve injury (IoN or inferior alveolar nerve constriction:
[24]). Moreover, the fraction of sympathetic fibers com-
posing the trigeminal nerve is 2.5 times lower than in
limb nerves [48].
Effects of dietary PUFAs on nociceptive behavior and 
neurogenic inflammation
The use of corn or soy as sources of dietary fat has been
associated to decreased expression of mechanical allody-
nia following partial sciatic nerve ligation (PSL, [16-18]).
Both types of fat contain similarly high levels of linoleic
acid (58%), a short chain (18 carbons) PUFA of the ω-6
family with 2 double bonds, but different levels of α-lino-
lenic acid (0.7% in corn, 6.8% in soy), a short chain PUFA
of the ω-3 family with 3 double bonds [19,49]. All the
above mentioned studies tested the rats for the presence of
allodynia for up to 10–14 days after PSL. After CCI-IoN
we confirmed that the long-term absence of PUFAs from
the diet elicited a decrease in mechanoresponsive thresh-
olds, and an overt mechanical allodynia 8 and 15 days
postsurgery, as judged from comparisons with responses
from the contralateral, undamaged side. At 15 days, rats
fed RD also started to display allodynia, but with response
thresholds still higher than rats fed MD. By 26 days post-
constriction, however, the allodynia reached the same
level irrespective of the diet used, suggesting that the "pro-
tective" effect of the PUFAs-rich diet would be temporary.
In the absence of a more prolonged follow-up, it remains
to be investigated whether the total duration of CCI-con-
nected neuropathic symptoms is affected by dietary lipid
content.
The removal of PUFAs from the diet also had a hitherto
unreported effect on neurogenic inflammation, consisting
of, 1, an increase of CAP-induced plasma extravasation in
the vibrissal pads of uninjured animals, and 2, an ipsilat-
eral reduction following CCI-IoN, while maintaining high
levels of extravasation in the contralateral side. Although
the mechanisms of this effect remain elusive, the relation-
ships existing between dietary lipids and inflammation
may shed some light on them. Dietary fatty acids, which
have been used to treat different inflammatory conditions
[20,22], have a complex influence on inflammatory
responses, which is mainly exerted by modifying the pro-
duction of inflammation-related eicosanoids and
cytokines. The simplest types of unsaturated fatty acids of
the ω-6 and ω-3 families cannot be synthesized in mam-
mals, but once ingested, are desaturated further and elon-
gated, giving rise to a series of long chain PUFAs, with
different, and in some aspects opposite effects on inflam-
matory processes [19,50]. While the ω-6 PUFAs boost the
production of potent proinflammatory eicosanoids (such
as prostaglandins and leukotrienes) and cytokines (such
as interleukins 1 and 6, and TNFα), ω-3 PUFAs antagonize
inflammatory responses by altering the eicosanoid pro-
duction through metabolic competition with the ω-6
PUFAs, by indirectly blocking the expression of proin-
flammatory genes such as NF-κB, or by generating antiin-
flammatory mediators, such as the recently described
resolvins, docosatrienes and neuroprotectins [50,51].Molecular Pain 2009, 5:8 http://www.molecularpain.com/content/5/1/8
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Dietary ω-3 PUFAs also alleviate chronic pain by mecha-
nisms other than their antiinflammatory effects, including
inhibition of neuronal protein kinases and blocking of
voltage-gated calcium channels involved in both inflam-
matory and NP processing, general reduction of the sym-
pathetic tone, and, perhaps, improvement of pain-
associated affective disorders and other psychiatric condi-
tions through largely unexplained mechanisms [20,52-
54]. Moreover, the absence of dietary α-linolenic acid may
enhance the formation of lysophosphatidic acid [55],
which is considered a critical mediator in the develop-
ment of NP, through direct actions on the primary sensory
neurons [56,57], and by inducing demyelination and
ephaptic cross-talk between fibers in dorsal roots and
peripheral nerves [58].
In contrast, because of their putative proinflammatory
effects, the possible effects on pain control of dietary ω-6
PUFAs have been essentially neglected. However, a clear-
cut opposite effect of dietary short chain PUFAs on pain is
questionable. Firstly, in naive rats it was an appropriate
ratio of ω-3:ω-6 fatty acids in diet (around 1:5), rather
than the absolute amount of ω-3 intake, which was asso-
ciated to an elevation of the withdrawal threshold to acute
thermal noxious stimuli [13,21]. This is consistent with
the fact that, because of the complex metabolic interac-
tion between the ω-families of dietary fatty acids, their
final outcome on the tissue fatty acid composition
depends more on the ratios between their different classes
than on their absolute amounts in the diet [19]. Secondly,
a significant positive correlation was recently reported
between the total intake of α-linolenic acid (an ω-3 PUFA)
and thermal hyperalgesia (but not mechanical allodynia)
after a PSL [49]. Moreover, the presence of both ω-3 and
ω-6 PUFAs' families in the intake could help reduce the
excitability of sodium channels involved in pain [59], par-
ticularly in injured nerves [60]. In our study, the lipid con-
tent of the olive oil used in MD to replace the fat present
in RD had just one-eighth of linoleic acid (6.3% vs. 50%),
and practically lacked α-linolenic acid (traces vs. 4.5%;
[61]), making olive oil a well-suited placebo in studies of
the antiinflammatory effect of PUFAs [62].
Conclusion
In summary, our findings demonstrate that dietary fat rich
in PUFAs reduces CAP-induced neurogenic plasma
extravasation in the trigeminal territory, and that a sus-
tained removal of PUFAs intake significantly alters the
mechanical allodynia and the plasma extravasation that
result from a unilateral CCI-IoN. In addition, the observa-
tion of contralateral effects of CCI-IoN, together with the
existence of natural asymmetries in some systems, warrant
caution against uncritically using the contralateral side as
control [63,64].
Methods
Experimental Animals
Adult male Sprague-Dawley rats (n = 108) from our own
colony, originating from Harlan (Harlan Iberica, Barce-
lona), were used. They were divided into 14 groups, com-
bining the various treatment protocols: Unilateral (left)
CCI-IoN, sham operation, or no surgery (naive); bilateral
application of CAP cream (1.6%), VEH (base cream) or
SAL to the vibrissal pad; and maintenance on RD or MD.
Animals' weight was recorded at six weeks of age, at the
surgery day and at the perfusion day.
Rats were housed under standard colony conditions (4
rats per cage). Food and water were supplied ad libitum,
and the animals were kept under a reversed 12:12 h dark/
light cycle. All experiments were carried out in accordance
with the Guidelines on Ethical Standards for Investigation
of Experimental Pain in Animals [65] and the European
Community's Council Directive 86/609/EEC, and the
study was approved by the Ethical Committee of our insti-
tution.
Surgery
Animals were i.m. anesthetized with a mixture of keta-
mine 55 mg/Kg, xylazine 15 mg/Kg, and atropine 0.2 mg/
Kg. The left IoN was exposed as described before [66,67].
One single ligature was tied loosely around the distal part
of the nerve using a polypropylene monofilament suture
(Surgipro 6.0). The mild degree of constriction apparently
did not block the circulation through the superficial
epineural vasculature of the IoN, as proposed by Bennett
and Xie [7] for the sciatic CCI, although the fan-like geom-
etry of the multi-fascicled IoN undoubtedly resulted in
different degrees of constriction on different fascicles. Spe-
cial care was taken to avoid an excessive compression of
the nerve, which hampered the development of allodynia
and resulted in more severe fiber loss (results not shown).
The wound was closed using silk sutures. In sham-oper-
ated rats the IoN was exposed on the left side using the
same procedure but the nerve was left untouched.
Diet
Two types of diet were used. The RD was the normal rat
chow provided by the animal holding facility (SAFE-A04,
Epinay-sur-Orge, France), containing 3.1% lipids derived
from barley, corn, soy, fish by-products and wheat. More
than half of the lipid content (54.5%) was the PUFAs lino-
leic acid (50%) and α-linolenic acid (4.5%). The MD
(Nutreco España, Toledo, Spain) was prepared ad hoc for
this study, and consisted of pellets of similar texture and
composition, except for the source of lipids (6%), which
were provided exclusively by olive oil, which contains a
much lower proportion of PUFAs (6.3% linoleic acid, and
traces of linolenic acid). Protein content in both diets
derived mostly from barley, wheat and soy, and reachedMolecular Pain 2009, 5:8 http://www.molecularpain.com/content/5/1/8
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roughly the same levels (16%). Six week-old rats were
exposed to either RD or MD for two additional weeks
before the surgeries. Each group was maintained on the
corresponding diet until the end of the experiment.
Behavioral Tests
Before every stimulation session, rats were habituated for
one hour daily to the testing room environment during 2–
3 days. The animals were placed in clear acrylic cages (30
× 30 × 20 cm) in order to reduce their field of exploration.
When the rat was still, with the four paws placed on the
ground, it was gently handled to ensure that it became
familiar with the experimenter and the approximation of
the test filaments, in order to minimize stress.
Tactile sensitivity in the vibrissal area was measured with
a set of eight calibrated von Frey monofilaments (North
Coast Medical, Inc. Morgan Hill, CA) ranging from 0.02 g
to 4.0 g. Each filament was applied to the bending point
five times at 15–30 s intervals, on five different points of
each vibrissal pad. The stimulus intensity was presented in
a sequential ascending order. The lowest force that evoked
50% of withdrawal responses was considered the thresh-
old. Responses to mechanical stimuli were explored bilat-
erally before the CCI surgery, and 8, 15 and 26 days after
surgery.
Determination of plasma extravasation
Eight and twenty-six days after CCI-IoN, and 1–2 days fol-
lowing the last behavioral test, rats were anesthetized with
pentobarbital (Dolethal, 50 mg/Kg, i.p.), had their snouts
shaved, and then they received an i.v. injection of EB
(Sigma; 50 mg/Kg of a 50 mg/ml solution in 0.9% saline)
in the tail vein. Immediately after injection, the appropri-
ate topical treatment (CAP, VEH, SAL) was applied bilat-
erally on the whisker pad. After 10 minutes the animals
were perfused through the ascending aorta with saline
(0.9% NaCl), and the trigeminal pads were quickly
removed and transferred to an oven at 56°C for 2 days.
Formamide (Sigma) was used to extract the EB out of the
tissue [34], and local extravasation was estimated from
the EB concentration measured with a spectrophotometer
(Molecular Devices) at a wavelength of 620 nm. Because
of the inherent intertrial variability, it was necessary to cre-
ate a standard curve for each experimental session, against
which the experimental results could be normalized. The
absorbance values over a range of EB-formamide concen-
trations were adjusted to a sigmoidal curve through non-
linear regression, and the concentration of EB correspond-
ing to saturation was used as 100% reference for all exper-
imental values obtained within the same session. The
group means and dispersion values were then represented
as percentages of saturation. Moreover, various animals
from different groups were coded and processed in every
measuring session.
Animal coding and statistics
After CCI surgery animals were coded by subcutaneous
electronic tags, so that all behavioral tests and EB proce-
dures were carried out with the experimenter blinded to
the type of diet consumed and treatment received by the
rats. For all statistical analysis Statgraphics Plus 4.0 were
used. Side comparisons within the same group were made
with a two-tailed t-test. For intergroup comparisons with
factors treatment (CAP, VEH or SAL) and manipulation
(CCI, sham or naive) a two-way analysis of variance
(ANOVA) was applied when parametric conditions were
met, or the non-parametric Kruskal-Wallis test otherwise.
If multiple comparisons yielded significance, two-by-two
comparisons were made with a t-test or Wilcoxon, as
appropriate. The significance level was set at p < 0.05.
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